Glucose Monitoring Devices - Global Strategic Business Report

The global market for Glucose Monitoring Devices is estimated at US$13.9 Billion in 2023 and is projected to reach US$19.2 Billion by 2030, growing at a CAGR of 4.7% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key market drivers and trends include technological leaps such as CGM systems, which provide real-time insights into glucose levels, and the integration of AI into glucose monitoring, AI is increasingly being incorporated into glucose monitoring systems to enhance the predictive accuracy of devices. These systems can analyze data over time to predict future trends in glucose levels, enabling preemptive management of potential issues. Artificial Intelligence (AI) is reshaping many aspects of healthcare, including diabetes management Government policies promoting better screening and monitoring, alongside patient education emphasizing self-monitoring, further drive adoption. Wearable glucose monitors that seamlessly integrate with everyday life are gaining traction. These devices continuously track glucose levels and offer the convenience of not having to perform multiple daily finger-prick tests.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Self-Monitoring Devices segment, which is expected to reach US$11.3 Billion by 2030 with a CAGR of a 3.8%. The Continuous Blood Glucose Monitoring Devices segment is also set to grow at 6.1% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $3.7 Billion in 2023, and China, forecasted to grow at an impressive 7.8% CAGR to reach $4.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Glucose Monitoring Devices Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Glucose Monitoring Devices Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Glucose Monitoring Devices Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of major players such as Abbott Diabetes Care, Inc., ACON Laboratories, Inc., AgaMatrix, Inc., and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 32 Featured):

• Abbott Diabetes Care, Inc.
• ACON Laboratories, Inc.
• AgaMatrix, Inc.
• Alive Technologies Pty. Ltd.
• ARKRAY, Inc.
• Ascensia Diabetes Care Holdings AG
• B. Braun Melsungen AG
• Beurer GmbH
• Dexcom, Inc.
• GlySens Inc.
• LifeScan, Inc.
• Medtronic plc
• Nova Biomedical Corporation
• Omron Healthcare Co., Ltd.
• Roche Diagnostics
• Senseonics Holdings, Inc.
• Terumo Corporation
• Trividia Health, Inc.
• Ypsomed Holding AG